NEOGEN CORP NEOG
Nasdaq · XNAS · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1989-08-23
NEOGEN CORP insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Moylan John Patrick | Chief Accounting Officer | 2026-06-03 | Tax withheld | 2,553 | $8.75 |
| Rocklin Amy M | Former Chief Legal Officer | 2026-05-18 | Option exercise | 35,183 | $9.29 |
| Rocklin Amy M | Former Chief Legal Officer | 2026-05-18 | Tax withheld | 10,241 | $9.29 |
| Moylan John Patrick | Chief Accounting Officer | 2026-05-04 | Tax withheld | 1,568 | $9.53 |
| Moylan John Patrick | Chief Accounting Officer | 2026-05-04 | Option exercise | 4,558 | $9.53 |
| Stacey Jennifer Evans | Chief Legal Officer | 2026-05-01 | Grant | 39,349 | $9.53 |
| Nassif Mikheal | CEO | 2026-02-17 | Buy | 23 | $10.94 |
| Nassif Mikheal | CEO | 2026-02-02 | Buy | 24 | $10.00 |
Source: SEC EDGAR filings · CIK 0000711377 · as of 2025-05-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.